Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study

J Diabetes Complications. 1992 Jan-Mar;6(1):12-8. doi: 10.1016/1056-8727(92)90043-k.

Abstract

The role of platelet aggregation in the pathogenesis of diabetes complications remains unclear despite a number of reports suggesting associations in univariate analyses. The Pittsburgh Epidemiology of Diabetes Complications Study is a prospective study initiated in 1985 to determine risk factors for the development of complications in insulin-dependent diabetes mellitus (IDDM). This report focuses on the cross-sectional correlation between platelet count and aggregation and IDDM complications, in 563 participants aged 18 years and older seen at baseline. Spontaneous whole blood platelet aggregation (SWBPA) and other hematological variables [hematocrit, total platelet count (TPC), red blood cell count (RBC), fibrinogen and white blood cell count (WBC)] were evaluated as risk factors for IDDM complications (nephropathy, neuropathy, and retinopathy) in the baseline cross-sectional data of the Pittsburgh Epidemiology of Diabetes Complications Study. SWBPA was determined by a method based on the percentage fall in platelet count after shaking a fresh citrated blood sample kept at 37 degrees C. Subjects with chronic aspirin use or on dialysis were excluded from analysis. An increased TPC was observed in subjects with overt nephropathy (291.4 +/- 65.1 versus 261.2 +/- 64.9, p less than 0.001) compared with subjects without nephropathy. Similar results were found for proliferative retinopathy. The association with nephropathy (but not with retinopathy) persisted in multivariate analyses.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Adult
  • Blood Cell Count*
  • Blood Pressure
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood*
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetic Nephropathies / blood*
  • Diabetic Nephropathies / epidemiology
  • Diabetic Neuropathies / blood*
  • Diabetic Neuropathies / epidemiology
  • Diabetic Retinopathy / blood*
  • Diabetic Retinopathy / epidemiology
  • Female
  • Glycated Hemoglobin / analysis*
  • Humans
  • Male
  • Pennsylvania / epidemiology
  • Platelet Aggregation*
  • Prevalence
  • Risk Factors
  • Sex Characteristics

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Glycated Hemoglobin A